In 1938, a chemist at DuPont named Roy Plunkett accidentally discovered polytetrafluoroethylene — the most slippery substance ever created, which would eventually be sold under the brand name Teflon. He’d been searching for a new refrigerant. Found something else entirely: a compound with almost no chemical reactivity. It wouldn’t burn. It wouldn’t react with almost any known substance. It wouldn’t break down at temperatures far above boiling water.
DuPont, recognizing the commercial potential, began producing it at scale, and within decades it had revolutionized cookware, clothing, food packaging, firefighting foam, stain-resistant carpeting, and hundreds of industrial applications. The compound and its chemical cousins — the per- and polyfluoroalkyl substances, or PFAS — were celebrated for their extraordinary durability.
Nobody in 1938 understood that the very property making PFAS commercially miraculous — their near-indestructibility — would eventually make them one of the most pervasive and persistent environmental health problems in modern industrial history.
PFAS are now detectable in the blood of 97 percent of Americans, according to Centers for Disease Control biomonitoring data. They are in the drinking water of communities across all fifty states. They are in produce grown on contaminated soil. They are in fish from contaminated waterways. They are in the breast milk of nursing mothers. They are in the bodies of polar bears in the Arctic and penguins in Antarctica.
Their common name — forever chemicals — is not marketing. It is chemistry. The carbon-fluorine bond in PFAS is among the strongest bonds in organic chemistry, and it resists biological, chemical, and photolytic degradation almost completely. When these compounds enter the environment, they stay.
This article provides a complete guide to PFAS avoidance: what these chemicals are, what the health evidence shows, where the most significant exposures come from, and what practical steps meaningfully reduce personal PFAS burden. The science is evolving rapidly, regulation is intensifying, and the information landscape is cluttered with both industry-funded minimization and activist overclaiming. The goal here is accuracy. Just accuracy.
PFAS Chemistry: The Forever Chemical Class
PFAS is not a single compound but a class of over four thousand manufactured chemicals all sharing the carbon-fluorine backbone that gives them their extraordinary chemical stability. Understanding the chemical diversity within PFAS matters because different compounds have different bioaccumulation potentials, different health effect profiles, and different effectiveness in various commercial applications — which in turn affects where they’re most likely encountered and which avoidance strategies are most relevant.
The “long-chain” PFAS — those with eight or more carbon atoms, including perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) — were the original workhorses of PFAS chemistry and have the most extensive health research, the most concerning documented effects, and have largely been phased out in the United States under voluntary agreements and regulatory pressure (PFOA by 2015, PFOS under the EPA’s Stewardship Program).
However, they persist indefinitely in the environment and in the bodies of people exposed before the phase-out, meaning legacy contamination is ongoing.
To replace long-chain PFAS, manufacturers shifted to “short-chain” PFAS and structurally modified compounds, including GenX chemicals (developed specifically as PFOA replacements), PFBS (perfluorobutane sulfonic acid, an PFOS replacement), and hundreds of other novel fluorinated compounds. The marketing premise was that shorter chains would be less bioaccumulative.
The accumulating evidence suggests this is partially true for serum accumulation but does not resolve environmental persistence or all health effects — GenX, for example, has been found to cause liver and kidney damage in animal studies and has been detected in drinking water sources in multiple countries.
The regulatory challenge of PFAS is partly a consequence of this chemical diversity: testing and regulating four thousand compounds individually is extraordinarily resource-intensive, and by the time evidence on specific compounds matures, manufacturers have often already substituted a different PFAS. This is the “regrettable substitution” pattern that has characterized PFAS regulation: replacing a regulated compound with a chemically similar alternative whose health effects are not yet characterized, creating the appearance of improvement while maintaining overall PFAS exposure.
The EPA’s April 2024 rule establishing MCLs for PFOA and PFOS, with additional limits for PFBS, GenX, and PFNA, represents an attempt to address this pattern more comprehensively than previous single-compound approaches.
Health Effects: What the Evidence Shows
The PFAS health literature has grown explosively in the past decade, driven by biomonitoring studies, epidemiological investigations of highly exposed communities, and systematic toxicological research. The weight of evidence now supports several health effects from PFAS exposure, with varying degrees of certainty across different outcomes.
The most consistently documented health effects of PFOA and PFOS exposure include: thyroid hormone disruption (multiple epidemiological studies have found inverse associations between serum PFAS and thyroid hormone levels, including in euthyroid individuals with subclinical effects), immune function impairment (a landmark 2012 study by Grandjean and colleagues in the Faroe Islands found that children with higher prenatal PFAS exposure had significantly lower antibody responses to routine vaccines, suggesting suppressed immune development), elevated serum cholesterol (prospective studies consistently find positive associations between PFAS exposure and total and LDL cholesterol), and kidney and testicular cancer (the “C8 Health Project” in West Virginia, which studied a community with decades of PFOA exposure from a DuPont facility, found increased risks of kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, and pregnancy-induced hypertension).
Reproductive and developmental effects are a particular concern. PFAS has been shown to cross the placental barrier and accumulate in cord blood, with implications for fetal development. Epidemiological studies have found associations between prenatal PFAS exposure and reduced birth weight, shorter gestational age, altered thyroid function in newborns, and reduced responsiveness to vaccines in infancy.
The Odense Child Cohort in Denmark found associations between maternal PFAS exposure and reduced growth in early childhood, with effects on insulin resistance and adiposity that persist into later childhood.
Liver toxicity is well-established in animal studies and is supported by human data: liver enzyme elevations have been found in populations with high PFAS exposure, and animal studies consistently show liver cell proliferation and fatty liver changes at PFAS exposure levels not dramatically above those found in highly exposed human populations.
The 2017 European Food Safety Authority assessment of PFAS concluded that a tolerable weekly intake for PFOS and PFOA of 13 and 6 nanograms per kilogram body weight per week, respectively, was appropriate based on liver effects — values that are exceeded by the measured intakes of a substantial fraction of the European population.
The characterization of health effects has been complicated by the industry-funded science that has historically dominated the PFAS research literature. Internal documents obtained through litigation against DuPont and 3M revealed that both companies had evidence of PFAS health effects in workers and animals dating to the 1960s and 1970s, decades before public scientific awareness.
The suppression of early findings and the strategic deployment of industry-funded research to cast doubt on the causal evidence has parallels to the tobacco industry’s science strategy and should inform interpretation of literature where industry funding is present.
Exposure Pathways: Where PFAS Actually Comes From
Understanding the most significant PFAS exposure pathways — ranked by contribution to total body burden — allows prioritizing avoidance efforts where they have the greatest impact. The exposure hierarchy varies somewhat by geography and lifestyle, but the following patterns emerge consistently from biomonitoring and dietary exposure modeling.
Contaminated drinking water is the most important modifiable exposure source in communities where PFAS contamination of water supplies is significant. The distribution of PFAS-contaminated water systems is geographically concentrated around military bases (where aqueous film-forming foam, or AFFF, has been used extensively and contains very high concentrations of PFOS-based chemistry), industrial facilities (particularly fluorochemical manufacturers, electroplating operations, and semiconductor manufacturers), and airports.
An estimated 200 million Americans — more than 60 percent of the population — drink water that contains detectable PFAS at any level; approximately 16 million drink water with PFAS at levels above the new EPA MCLs.
Dietary exposure through contaminated food represents the largest single exposure pathway for people whose drinking water is not significantly contaminated. Fish from PFAS-contaminated water bodies are particularly high in PFAS, with high-fat freshwater fish accumulating PFAS to concentrations that can represent the primary dietary exposure source for regular consumers.
A 2022 study by Hu and colleagues at Dartmouth found that eating one serving per year of freshwater fish caught in the Great Lakes or Southeast US provided PFAS exposure equivalent to drinking contaminated water at high levels for an extended period. Produce grown using PFAS-contaminated irrigation water or sewage sludge fertilizer (biosolids) also concentrates PFAS.
Food packaging and food contact materials are a significant but declining exposure pathway as PFAS in food contact uses is increasingly regulated. Microwave popcorn bags, pizza boxes, fast food wrappers, and some baked goods packaging have historically contained PFAS for grease and moisture resistance. Studies have measured PFAS migration from packaging into food, with higher migration at elevated temperatures (microwaving) and in high-fat foods (which are better solvents for fluorinated compounds).
Several major manufacturers and restaurant chains have committed to eliminating PFAS from food packaging, and some US states (including California, Washington, and Maine) have enacted legislation banning PFAS in food contact materials.
Non-stick cookware (PTFE-based coatings including Teflon) presents a more detailed exposure picture. PTFE itself is relatively inert at normal cooking temperatures and does not migrate significantly into food when cookware is in good condition.
The PFAS health concerns with non-stick cookware come primarily from two sources: PFOA used in the manufacturing process (largely eliminated by 2015 in the United States) and the breakdown products when non-stick coatings are overheated above approximately 260 degrees Celsius (500 degrees Fahrenheit), at which temperatures PTFE begins to degrade and can release fluoropolymer particles and gases.
Normal cooking temperatures — even searing — do not typically exceed this threshold in properly used cookware; empty non-stick pans can exceed it rapidly on high-heat burners.
Stain-Resistant and Water-Repellent Products: A Hidden Exposure Category
Carpet and upholstery treatments represent a domestic PFAS source that has been widely used for decades. A 2016 study by Beesoon and colleagues found that children living in households with PFAS-treated carpet had significantly higher serum PFAS concentrations than children in homes without PFAS-treated carpet, after controlling for other exposure variables.
The mechanism involves both dermal contact (particularly in young children who spend time on the floor) and dust ingestion (PFAS migrates from treated surfaces into house dust, which is ingested at higher rates by toddlers).
Stain-resistant and water-repellent finishes on clothing — most commonly found on outdoor apparel and athletic wear marketed as DWR (durable water repellent) — have historically been based on long-chain PFAS (C8 chemistry) and, following their phase-out, on short-chain PFAS alternatives. The outdoor industry trade group bluesign and several major brands (Patagonia, Gore-Tex, Outdoor Research) have made commitments to transition to non-fluorinated DWR alternatives, which are now technically viable for most outdoor apparel applications.
When purchasing water-resistant apparel, looking for products marketed as “PFC-free” or “fluorocarbon-free” DWR identifies those using non-PFAS alternatives.
Washing PFAS-treated textiles releases PFAS into wastewater — a pathway that contributes to the PFAS load in surface water and, where wastewater treatment plant effluent is used for agricultural irrigation, in food. The released PFAS from washing is not retrievable once in the wastewater stream, making prevention (not purchasing PFAS-treated textiles) more effective than remediation.
Consumer demand for PFC-free alternatives has accelerated manufacturer transitions substantially, and non-fluorinated DWR performance has improved to the point where most recreational outdoor users can meet their performance needs without fluorinated treatments.
PFAS in Personal Care Products and Cosmetics
PFAS in personal care products represent a poorly publicized exposure pathway that has received increasing attention since studies in the late 2010s began documenting their prevalence. A 2021 study by Whitehead and colleagues at the University of Notre Dame, published in Environmental Science and Technology Letters, analyzed 231 cosmetic products from major US retailers and found PFAS in 56 percent of foundation and eye products, 48 percent of lip products, and over 80 percent of waterproof mascara and foundations.
The PFAS were often not disclosed on ingredient labels, identified instead by PFAS-related ingredients (including compounds with “perfluoro” or “PTFE” in their names) or inferred from the presence of fluorine detected by X-ray fluorescence analysis.
The health concern with PFAS in cosmetics is dermal absorption combined with oral ingestion for lip products. Skin is not an absolute barrier to PFAS absorption — transdermal absorption has been demonstrated for several PFAS compounds, with absorption rates dependent on the specific compound, vehicle, and area of application. For lip products, an additional direct ingestion pathway exists through normal lip-licking behavior.
A 2019 Environmental Working Group analysis found PFAS in lip gloss, lipstick, and foundation brands including several major market leaders.
The Campaign for Safe Cosmetics and Environmental Working Group both maintain online databases (EWG Skin Deep) that allow searching specific product formulations for PFAS ingredients. Avoiding products containing “PTFE,” “perfluoro” compounds, or “polytetrafluoroethylene” is the primary ingredient-label-based avoidance strategy. “Waterproof” formulations are higher risk than non-waterproof alternatives, as PFAS are commonly used to create water resistance in foundations and mascara.
Mineral-based and “clean beauty” cosmetic lines have generally moved away from fluorinated ingredients, and many are certified PFAS-free through third-party verification programs.
Testing for PFAS in Your Body and Environment
For individuals concerned about PFAS exposure, testing options exist at both personal and environmental levels. Understanding what these tests measure and how to interpret them helps make informed decisions about exposure reduction priorities.
Serum PFAS testing measures concentrations of specific PFAS compounds in blood serum. Laboratory testing through specialized environmental health laboratories (Quest Diagnostics and Labcorp both offer PFAS serum panels) measures a panel of ten to twenty-five PFAS compounds, providing a measure of total body burden and the relative contribution of different compounds.
Interpreting results requires comparison to reference ranges from national biomonitoring data (NHANES) — levels above the 95th percentile for age and sex suggest above-average exposure that may warrant investigation of sources and stricter avoidance measures.
Drinking water PFAS testing using a certified laboratory provides the most direct information about the primary modifiable exposure source for most people. State-certified laboratories for PFAS analysis are listed on state environmental agency websites. The comprehensive EPA Method 533 and Method 537.1 tests detect a broad range of PFAS compounds at low levels (a few parts per trillion). Testing costs approximately $150 to $400 for a comprehensive panel, substantially less than the ongoing health and financial costs of persistent contamination.
Consumer PFAS test kits for home use are available for both water and some product testing, though their analytical sensitivity and specificity for the full range of PFAS compounds is generally lower than certified laboratory methods. They provide useful screening information when certified laboratory testing is not accessible or affordable, and a positive result should be confirmed by certified laboratory analysis.
Reducing PFAS Exposure: A Practical Priority Framework
Given the ubiquity of PFAS exposure sources, a priority framework based on exposure magnitude and modifiability prevents both the paralysis of trying to address everything simultaneously and the ineffectiveness of addressing only trivial sources while missing significant ones.
Priority one is drinking water. Test your water for PFAS if you have not done so. If contamination is confirmed above the new EPA MCLs (4 ppt for PFOA, 4 ppt for PFOS, with additional limits for other PFAS), install a certified reverse osmosis system at your primary drinking and cooking tap. NSF/ANSI Standard 58 and Standard 471-certified RO systems reduce PFAS by 90 to 99 percent and represent the most cost-effective single exposure reduction intervention for contaminated supplies.
If your water utility confirms contamination is below MCLs but above your personal health threshold, the same filtration recommendation applies.
Priority two is food exposure reduction. Avoid or significantly limit consumption of freshwater fish caught in contaminated water bodies — check your state’s fish advisory program for specific guidance on your area’s waterways. Avoid or reduce fast food consumption (a 2019 study by Susmann and colleagues found significant positive associations between fast food consumption frequency and serum PFAS levels, attributable to food packaging and handling).
Choose produce from known uncontaminated sources where possible, particularly root vegetables (which accumulate soil PFAS more than above-ground produce).
Priority three is replacing PFAS-containing consumer products over time. Non-stick cookware with damaged or scratched coatings should be replaced — with stainless steel, cast iron, or carbon steel for most cooking applications, or with PFAS-free ceramic-based non-stick coatings for lower-temperature applications. Stain-resistant carpet and upholstery can be gradually replaced with untreated alternatives as normal replacement cycles occur. New carpet and upholstery purchases should specify no PFAS treatment. Clothing purchases should favor PFC-free DWR-treated outdoor gear.
Priority four is cosmetic and personal care product substitution. Review the most frequently used products against the EWG Skin Deep database. Replace any products containing PTFE, perfluoro compounds, or fluoropolymers with alternatives from lines that have committed to PFAS-free formulations. Waterproof makeup formulations carry higher risk than standard formulations and can often be replaced with products providing comparable aesthetics without fluorinated chemistry.
PFAS Chemistry Forever Q&A
Q: Will PFAS levels in my blood decrease if I reduce exposure?
Yes, though the timeline varies by compound. PFAS accumulate in the body because they bind to serum proteins and are not efficiently excreted. Elimination half-lives (the time required to reduce serum levels by 50 percent with zero ongoing exposure) range from approximately four years for PFOS to three and a half years for PFOA. This means that meaningful reductions in body burden from reducing exposure are measurable over years rather than weeks.
More recent short-chain PFAS replacements (like PFBS) have shorter half-lives (approximately one month) and are more rapidly eliminated. The long half-lives of legacy long-chain PFAS mean that sustained exposure reduction — avoiding contaminated water, reducing food sources — produces gradual but real and meaningful decreases in body burden over a multi-year period.
Q: Is non-stick cookware safe to use, or should I replace all of it?
Non-stick cookware in good condition (no scratches, chips, or peeling of the coating) used at temperatures below 260 degrees Celsius (500 degrees Fahrenheit) with metal utensils avoided poses relatively low PFAS exposure risk. The PFOA used in manufacturing was largely eliminated by 2015, and the PTFE coating itself does not migrate significantly into food under normal use conditions.
The risk increases with damaged cookware, use on very high heat (particularly empty pans on high-heat burners), and extended use beyond the normal coating lifespan. Replacing damaged non-stick cookware with stainless steel, cast iron, or carbon steel is advisable; preemptive replacement of well-maintained non-stick cookware is a personal risk tolerance decision rather than a clinical necessity.
Q: How do I know if my community’s water is contaminated with PFAS?
The most current and comprehensive source is the EWG’s PFAS contamination map and database, which aggregates utility-reported data and includes contaminated sites not yet captured in annual water quality reports. Your utility’s Annual Water Quality Report is another source, though utilities are not yet universally required to report all PFAS compounds.
The EPA’s UCMR 5 (Unregulated Contaminant Monitoring Rule 5) required large utilities to test for PFAS from 2023 to 2025 — these results are publicly available through the EPA’s database. For private well users, independent laboratory testing is the only reliable assessment method.
Q: Are microwave popcorn bags still a PFAS concern?
Major US microwave popcorn manufacturers largely transitioned away from long-chain PFAS in bags by 2015 under voluntary FDA programs. However, some products may still use short-chain PFAS replacements, and generic or imported products may not have made the same transition. Checking the manufacturer’s PFAS commitment (typically available on their website or through certification programs) is the most current approach.
Air-popped popcorn prepared in a standard pot or electric air popper avoids the packaging concern entirely while maintaining all the nutritional benefits at lower cost.
Q: Do children have higher PFAS exposure risk than adults?
Yes, through several mechanisms. Children have higher body-weight-adjusted exposure from the same food and water sources (they drink more water relative to body weight, breathe more air, and consume more food relative to body weight than adults).
Children also have specific exposure pathways that are more relevant than for adults: floor-level PFAS dust ingestion from PFAS-treated carpet (children spend more time on the floor), hand-to-mouth behavior that increases ingestion of surface PFAS, and potentially different developmental sensitivity at several biological targets (thyroid function, immune development) that may make equivalent exposures more harmful.
The prenatal period is particularly critical — PFAS cross the placenta, and in utero exposure at developmentally sensitive windows may produce effects disproportionate to the dose.
The forever chemical story is a study in delayed reckoning. The science knew before the regulation acted. The regulation acted before the public understood. The public is now understanding before much of the exposure has changed. Progress in environmental health has always followed this pattern: the gap between knowing and acting represents a deficit that we pay with our biology. The fact that PFAS avoidance is now possible and practical, even before the regulatory environment has fully caught up, is a form of individual agency over a problem that was not of our individual making.
Roy Plunkett died in 1994, having lived to see his accidental discovery become a global commercial phenomenon. He received DuPont’s Lavoisier Medal, a company honor. Whether he knew what the internal documents now show — that the company had evidence of harm for decades before disclosing it — is not public record.
What is public record is everything those documents revealed: that the indestructibility that made PFAS commercially valuable made them environmentally catastrophic, and that the people who most needed to know were the last to be told. Consider yourself better informed now. Act accordingly.
PFAS in Firefighting Foam: The Military and Airport Legacy
AFFF has been used since the 1960s at military air bases and civilian airports for fire suppression, particularly for training burns and emergency responses involving aviation fuel fires. AFFF formulations contain PFOS and PFOA at concentrations of 1 to 10 percent by weight — enormously higher than any consumer product PFAS content.
Decades of training exercises involving AFFF discharge directly onto soil and into drainage systems have deposited thousands of pounds of PFAS per base at hundreds of military installations across the United States.
The Environmental Working Group has identified more than 2,800 military and industrial sites in the US with known or likely PFAS contamination, with contaminated groundwater plumes that extend beyond base boundaries in many cases.
The Department of Defense estimates that approximately 700 bases have drinking water on or near them with PFAS above the old health advisory levels, and the remediation costs to address this legacy contamination are estimated in the hundreds of billions of dollars — a public health liability created by decisions made without adequate understanding of long-term environmental consequences.
For individuals who live near military installations, former military land, or major civilian airports, PFAS drinking water testing is particularly important. State environmental agency websites typically maintain maps of known AFFF contamination plumes, and the EPA’s contaminant occurrence map provides federal data.
Communities affected by AFFF contamination have also been the subjects of health studies documenting elevated serum PFAS and associated health effects, providing some of the strongest human evidence for PFAS toxicity in the literature (including the studies of Pease Air Force Base communities in New Hampshire and Wurtsmith Air Force Base communities in Michigan).
The PFAS Regulatory Landscape: What Has Changed and What Is Coming
PFAS regulation has accelerated dramatically since 2020, and understanding the current and forthcoming regulatory landscape helps anticipate which products and exposure sources are likely to become less PFAS-intensive over the coming years, and which require active individual avoidance in the interim.
The EPA’s April 2024 National Primary Drinking Water Regulation for PFAS is the most consequential federal drinking water rule in decades. It establishes MCLs of 4 ppt for PFOA and PFOS individually, 10 ppt for PFNA and PFHxS, and a hazard index approach for GenX chemicals and PFBS that accounts for their combined effects. Water utilities must achieve compliance by 2029, meaning that water systems currently above these limits have a five-year window to install treatment or change sources.
This regulatory timeline creates a period in which consumers in affected areas should be taking individual protective measures while awaiting utility compliance.
State-level PFAS regulations in many cases go further than federal standards. Maine, Vermont, California, Minnesota, and several other states have enacted legislation restricting PFAS in food packaging, carpets, upholstery, apparel, cookware, ski wax, and other consumer products. These state regulations have typically been more protective of public health than federal standards, and manufacturer compliance with state requirements often results in PFAS-reduced products being available nationally.
The pattern of state-level action leading federal action (California’s auto emissions standards later adopted federally, for example) suggests that current state PFAS restrictions will likely influence or be superseded by federal rules within the decade.
The European Union’s PFAS regulation has been more aggressive than US federal regulation. The EU’s REACH regulation has restricted specific PFAS in various applications, and the EU’s Drinking Water Directive, which took effect in 2021, establishes a 0.1 µg/L (100 ppt) limit for total PFAS sum (20 PFAS compounds measured) and a 0.5 µg/L limit for total PFAS including all compounds — values significantly more conservative than current US federal limits for individual compounds.
EU chemical regulation frequently foreshadows global manufacturing changes, as multinational companies often find it easier to reformulate globally than to maintain separate supply chains for EU versus non-EU markets.
The broader “essential use” framework is gaining traction as a regulatory philosophy: rather than addressing PFAS uses one compound at a time, limiting PFAS use to applications where no alternative exists and where the benefit is essential to health and safety (certain medical devices, specific aerospace and defense applications) provides a more comprehensive approach than the regrettable substitution cycle of compound-by-compound regulation.
The Organization for Economic Cooperation and Development (OECD) has developed an essential use concept for PFAS, and several European countries have proposed a REACH restriction on all non-essential PFAS uses — a proposal that, if enacted, would be the most sweeping PFAS regulatory action in history.
PFAS Alternatives: What Industry Is Using Instead
Understanding what non-PFAS alternatives exist for major PFAS applications helps both evaluate the feasibility of PFAS elimination and identify which product categories can be reliably PFAS-free in the market today.
For non-stick cookware, PTFE-free alternatives include: ceramic-based non-stick coatings (sol-gel ceramic particles bonded to a substrate, without fluorine chemistry), seasoned cast iron and carbon steel (providing non-stick performance through polymerized oil coatings), stainless steel (requiring appropriate heat and fat management technique), and enameled cast iron (for high-heat applications).
None of these are perfect substitutes for PTFE-based non-stick in all applications — PTFE remains the highest-performance non-stick surface — but for most cooking applications they perform adequately, and the health and environmental trade-off increasingly favors alternatives.
For DWR textile treatments, non-fluorinated alternatives based on wax, silicone, polyurethane, and bio-based chemistries have been commercially developed and are now used by multiple major outdoor brands. The performance gap between fluorinated and non-fluorinated DWR has narrowed substantially: for most outdoor recreational applications (hiking, camping, casual outdoor use), non-fluorinated DWR provides adequate water repellency and durability.
High-performance applications (mountaineering, extended backcountry expeditions in sustained precipitation) may still show performance differences under extreme conditions, but the outdoor industry has largely concluded that the environmental and health costs of fluorinated DWR are not justified for the majority of consumer applications.
For food packaging, unbleached paper, compostable PLA-based materials, aluminum, glass, and barrier coatings based on starches, proteins, and silicones are all commercially deployed as PFAS-free alternatives. Fast food chains including McDonald’s, Whole Foods, and Chipotle have committed to PFAS-free packaging transitions, driven partly by state mandates and partly by consumer pressure. The transition is not complete across the industry, but is accelerating as alternative material costs have fallen and regulatory pressure has increased.
Chelation, Sauna, and Detoxification Strategies: What Evidence Shows
Given that PFAS have been measured in the blood of essentially all Americans, and that their elimination half-lives are measured in years, it is understandable that people with high serum PFAS levels seek accelerated elimination strategies. The evidence for most proposed PFAS “detoxification” protocols is limited, but some biological strategies have theoretical support and early research.
Sauna use has attracted particular interest as a potential PFAS elimination pathway. PFAS are hydrophobic (water-repelling) and do not concentrate significantly in sweat, making sweat an inefficient elimination route for most PFAS compounds. However, several studies — most notably analyses of Finnish sauna users and military personnel using saunas — have found lower serum PFAS concentrations in regular sauna users compared to non-users, after controlling for known confounders.
The mechanism is poorly understood, possibly involving indirect effects on metabolic and hepatic function rather than direct sweat elimination. A 2023 study by Genuis and colleagues reported detecting various PFAS in sweat samples, suggesting some sweat-mediated elimination does occur. This evidence is suggestive but not definitive, and regular sauna use cannot be recommended as a proven PFAS reduction intervention — though its cardiovascular and other documented health benefits make it worth considering for other reasons.
Cholestyramine, a bile acid sequestrant used pharmaceutically for cholesterol management, has been proposed as a PFAS elimination agent based on the enterohepatic recirculation of PFAS — a process by which PFAS excreted in bile from the liver are reabsorbed in the intestine and returned to circulation. By binding PFAS in the intestinal lumen before reabsorption, cholestyramine theoretically disrupts this recirculation and increases fecal elimination.
Preliminary data from studies in laboratory animals and limited human case series are modestly supportive, but no rigorous clinical trial has been conducted. Cholestyramine is a pharmaceutical agent with significant gastrointestinal side effects and requires medical prescription — it is not appropriate for unsupervised use as a PFAS elimination strategy.
The most strong evidence-based approach to reducing body burden remains exposure reduction: eliminating contaminated drinking water as the primary source, reducing dietary PFAS intake through food selection, and minimizing product-based exposures. These measures, sustained over years, produce measurable reductions in serum PFAS that biological elimination strategies have not yet been shown to achieve more rapidly than the body’s natural processes alone.
References